Top Markets
#1 Velas Velas +367.73%
#2 Gravity Gravity +48.81%
#3 Galxe Galxe +41.61%
#4 Infinity Ground Infinity Ground +30.19%
#5 Audiera Audiera +29.99%
#6 Fetch.ai Fetch.ai +26.67%
#7 Derive Derive +25.50%
#8 Wiki Cat Wiki Cat +25.33%
#9 Aria.AI Aria.AI +20.16%
#10 Fuzzybear Fuzzybear +18.58%
Coin of the day
Velas Velas
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Novo Nordisk A/S Novo Nordisk A/S

Novo Nordisk A/S

NVO
Pozycja w akcjach #96
Novo Nordisk A/S, a healthcare company, engages in the research, development,... Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Cena akcji
$38.41
Kapitalizacja rynkowa
$170.67B
Zmiana (1 dzień)
1.17%
Zmiana (1 rok)
-49.92%
Kraj
DK
Handel Novo Nordisk A/S (NVO)

Kategoria

Healthcare
Kapitalizacja rynkowa
Przychody
więcej
Zyski
Historia cen
Wskaźnik P/E
Wskaźnik P/S
Wskaźnik P/B
Marża operacyjna
Zysk na akcję (EPS)
Podziały akcji
Dywidendy
Stopa dywidendy
Akcje w obrocie
Historia ceny akcji dla Novo Nordisk A/S (NVO)
Najwyższa cena zamknięcia: $38.35 dnia 2026-03-01

Najniższa cena zamknięcia: $28.10 dnia 2007-07-01
Historia cen akcji firmy Novo Nordisk A/S od 2007 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) 17.70%
2025 -51.54%
2024 1.70%
2023 -23.31%
2022 17.33%
2021 57.90%
2020 22.89%
2019 26.29%
2018 -13.92%
2017 49.77%
2016 -37.97%
2015 26.27%
2014 24.70%
2013 10.84%
2012 43.58%
2011 6.03%
2010 -4.61%
2009 14.74%
2008 -41.68%
2007 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $465.49 -7.78%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 $755.73 13.32%
US
UCB SA UCB SA
UCB SA
UCB.BR
 $302.35 54.55%
BE
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $99.21 -36.97%
AU
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $703.96 16.36%
NL